Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils.
Renesto
P
P
Unité de Pharmacologie Cellulaire, Institut Pasteur, Paris, France.
Ferrer-Lopez
P
P
Chignard
M
M
D056649:Cathepsin G; D002403:Cathepsins / Q000037:antagonists & inhibitors*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects*; D015539:Platelet Activation / Q000187:drug effects*; D011506:Proteins; D012697:Serine Endopeptidases; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D015843:Serpins
D011506:Proteins; D015842:Serine Proteinase Inhibitors; D015843:Serpins; C028656:eglin proteinase inhibitors; D009240:N-Formylmethionine Leucyl-Phenylalanine; D006493:Heparin; D002403:Cathepsins; D012697:Serine Endopeptidases; C534094:CTSG protein, human; D056649:Cathepsin G